ProDGNE Meeting 2022

31 May 2022

The ProDGNE consortium invites you to register for the ProDGNE Meeting 2022 which will take place on 31st May in Lisbon, Portugal. The meeting aims to present ProDGNE, discuss impactful research in GNE Myopathy and expand the research network while building a long-term partnership where patients are central partners, key drivers and decision makers in R&D. Teresinha Evangelista, our Coordinator will participate in this meeting.

ProDGNE is a 3 year transnational pre-clinical research project which aims to develop an innovative therapeutic compound to treat GNE Myopathy, an ultra rare muscle disease affecting young adults. The project is funded in the framework of the EJP RD JTC 2020 “Pre-Clinical Research to Develop Effective Therapies for Rare Diseases”.

Deadline for abstract submission through this online form: 10th May 2022

Venue

NOVA School of Science and Technology | FCT NOVA

Sala Ágora – Biblioteca (Room Ágora – Library building)

2829-516 Caparica, Portugal

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern